DCM Shriram Fine Chemicals Ltd (DSFCL)
🎯 Key Takeaways
- DCM Shriram Fine Chemicals Ltd is in a fragile financial and operational phase marked by persistent losses and declining margins, despite stable promoter ownership. The company has swung between small profits and deeper losses over the past two years, with recent quarters showing deteriorating profitability.
- Revenue declined 2.5% QoQ to ₹91 in Q1FY27.
- ⚠️ 1) Persistent operating losses and negative cash flow from operations in recent quarters despite stable revenue, signaling underlying margin compressi
- Market Cap
- ₹253
- P/B Ratio
- 1.20
- ROE
- -2.5%
- ROCE
- -1.6%
- Debt/Equity
- 0.04
- Div Yield
- 1.38%
- Promoter
- 50.1%
📖 The Story
DCM Shriram Fine Chemicals Ltd is in a fragile financial and operational phase marked by persistent losses and declining margins, despite stable promoter ownership. The company has swung between small profits and deeper losses over the past two years, with recent quarters showing deteriorating profitability. While promoter consolidation suggests confidence in long-term control, the lack of operational recovery raises concerns about execution or market positioning in a competitive chemical segment.
📰 What's Happening
In late August 2026, promoter Urvashi Tilakdhar increased her stake by 3.52% through an inter-se transfer among promoters, raising her holding to 30.94%, while Akshay Dhar and Aditi Dhar each reduced their stakes to zero via off-market sales. These transactions reflect internal promoter rebalancing rather than a shift in control, with total promoter ownership remaining steady at 50.11%. The moves comply with SEBI SAST Regulation 29(2) and involve no open market purchases or external investors, indicating a quiet consolidation rather than a strategic inflection point.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 113 | 97 | 97 | 93 | 91 |
| Operating Profit | 5 | -4 | -2 | -5 | 3 |
| OPM % | 4.8% | -3.8% | -1.9% | -4.9% | 3.5% |
| Net Profit | 4 | -3 | -1 | -4 | 3 |
| EPS | ₹0.51 | ₹-0.29 | ₹-0.17 | ₹-0.44 | ₹0.30 |
The company's revenue has plateaued around ₹90-97 crore in recent quarters, but operating performance has sharply declined, with operating profit turning negative in Q1FY27 (₹3 crore) compared to ₹5 crore profit in Q4FY25. Margins have eroded from 4.8% two years ago to -4.9% in the latest quarter, and net losses have widened to ₹3 crore despite modest revenue stability. This suggests rising cost pressures or pricing headwinds that management has not yet addressed, undermining confidence in near-term profitability recovery.
🔮 Management Outlook & What's Next
There is no explicit forward guidance or strategic update provided in the available filings. Management has not articulated a clear path to margin improvement or revenue growth, and the absence of commentary on operational outlook leaves investors without insight into how the company plans to reverse its earnings decline. The focus appears to be on shareholding restructuring rather than business transformation or capital deployment for growth.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity Capital | 17 | 17 |
| Reserves | 198 | 194 |
| Borrowings | 13 | 8 |
| Total Liabilities | 308 | 295 |
| Fixed Assets | 130 | 103 |
| Investments | 23 | 33 |
| Total Assets | 308 | 295 |
The balance sheet remains conservatively structured with negligible debt (₹8 crore as of March 2026) and stable equity and reserves, indicating limited capital intensity or expansion. Total assets have slightly declined, and there is no evidence of significant reinvestment or new liabilities, suggesting a defensive posture rather than aggressive growth or modernization. The company appears to be preserving capital rather than deploying it for recovery or expansion.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +16 |
| Investing | +11 |
| Financing | -6 |
| Net Cash Flow | +21 |
👥 Shareholding Pattern
| Category | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|
| Promoters | 50.1% | 50.1% | 50.1% |
| FII | 1.5% | 1.5% | 1.0% |
| DII | 12.8% | 12.0% | 11.4% |
| Public | 24.8% | 25.6% | 26.6% |
| # Shareholders | 44,490 | 43,570 | 42,493 |
Institutional investor shareholding has modestly increased from 1.48% to 1.03% in FII and from 12.01% to 11.36% in DII over the last two quarters, while promoter stake remains tightly held at 50.11%. The growing retail investor base (26.62% and 42,493 shareholders) suggests rising market interest, but the modest accumulation by FIIs and DIIs indicates limited institutional conviction. There are no signs of distress selling or large-scale exits, but foreign interest remains marginal.
⚖️ Peer Comparison — Chemicals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| PIDILITIND | 1.50 L Cr | 56.5 | 33.4% | — | 0.01 |
| SRF | 72,171 | 33.4 | 15.6% | — | 0.36 |
| LINDEINDIA | 52,799 | 96.6 | 17.5% | — | 0.00 |
| FLUOROCHEM | 48,503 | 79.3 | 9.6% | — | 0.34 |
| NAVINFLUOR | 42,232 | 53.4 | 22.2% | — | 0.31 |
| GODREJIND | 35,513 | 30.2 | 9.2% | — | 4.57 |
| HSCL | 33,663 | 41.8 | 20.7% | — | 0.16 |
| AETHER | 23,246 | 98.6 | 13.8% | — | 0.08 |
| DEEPAKNTR | 20,783 | 26.5 | 15.3% | — | 0.26 |
| CASTROLIND | 19,792 | 18.6 | 76.2% | — | 0.00 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1) Persistent operating losses and negative cash flow from operations in recent quarters despite stable revenue, signaling underlying margin compression. 2) Lack of strategic clarity or growth initiatives disclosed by management, leaving the business without a visible catalyst for improvement. 3) High retail shareholding and thin institutional interest may lead to volatility if retail sentiment shifts. 4) The chemical industry's competitive and capital-intensive nature poses ongoing pressure, especially without scale or pricing power.
📋 Recent Filings
- 🟡 Board Meeting2026-09-25DCM Shriram Fine Chemicals announced the resignation of Independent Director Rohit Bhandari effective September 24, 2026, due to personal and professi…
- 🔴 Announcement2026-09-25DCM Shriram Fine Chemicals announced the resignation of Independent Director Rohit Bhandari effective September 24, 2026, due to personal and professi…
- Announcement2026-09-21DCM Shriram Fine Chemicals Ltd disclosed board approval to pay a combined fine of Rs. 6.04 crores to BSE and NSE for delayed compliance with SEBI LODR…
- Announcement2026-09-21DCM Shriram Fine Chemicals announced that its trading window will close on October 1, 2026, ahead of the upcoming un-audited financial results for the…
- 🔴 Announcement2026-09-17DCM Shriram Fine Chemicals announced the resignation of Independent Director Vijay Anand effective September 17, 2026, citing pressing professional co…
- 🟡 Board Meeting2026-09-17DCM Shriram Fine Chemicals announced the resignation of Independent Director Vijay Anand effective September 17, 2026, citing pressing professional co…
- 🟡 voting results2026-09-09The postal ballot notice dated September 3, 2026, proposes five special resolutions for shareholder approval through remote e-voting. These include th…
- 🔴 Announcement2026-09-09DCM Shriram Fine Chemicals announced the resignation of Independent Director Venkata Rama Subbu Behara effective September 8, 2026, due to board restr…
- 🟡 Board Meeting2026-09-09DCM Shriram Fine Chemicals announced the resignation of Independent Director Venkata Rama Subbu Behara effective September 8, 2026, due to board restr…
- 🟡 Board Meeting2026-09-03The board approved the appointment of Anil Kumar Khaitan as an additional independent director for five years effective September 4, 2026, pending sha…
🧠 Analyst's Read
The company is navigating a quiet but fragile phase marked by financial instability and operational stagnation, with promoter consolidation offering little reassurance without a clear recovery plan. Investors should watch for any shift in management's strategic narrative or early signs of margin stabilization, as current trends suggest further earnings pressure may persist without intervention.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-30.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when DSFCL files new disclosures
Track DSFCL filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track DSFCL — FreeFree account · 2 AI queries/day